47
Apogem Secondary Fund VII, LP updates its Form D — $776.2M sold
Fund raise update · Secondaries · Raising · Offering $1.3B · Sold $776.2M · NEW YORK, NY · filed 2025-02-14
3(c)(7) — qualified purchasers
47
Apogem Secondary Fund VII, LP updates its Form D — $1.21B sold
Fund raise update · Secondaries · Raising · NEW YORK, NY · Form D/A filed 2026-02-13 · all Apogem Secondary vehicles
$100M+ sold3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| N/A M Apogem Capital LLC | Investment Manager |
| John M Grady | Chief Financial Officer of Apogem Capital LLC, the Issuer's Investment Manager |
| N/A ASF VII GP, LLC | General Partner of the Issuer |
| Michael M Zeleniuch | Managing Director of Apogem Capital LLC, the Issuer's Investment Manager |
| Christopher M Stringer | Managing Director and Head of Private Equity of Apogem Capital LLC, the Issuer's Investment Manager |
| Michael M Griech | Managing Director of Apogem Capital LLC, the Issuer's Investment Manager |
Signed by John M. Grady, CFO of Apogem Capital LLC, the Issuer's Investment Manager.
Placement agents / sales compensation: NYLIFE Distributors LLC; Alvine Capital AB (ACAB); Alvine Capital Management Limited
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.